StockDriftsStockDriftsTop 9 Euclidean Capital LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| VEU | VANGUARD INTL EQUITY INDEX F | 61.76% | 3.24M | $271.6M | +0.00%(+0) | $64.01(+34.58%) | 2026-06-30 | |
| VTV | VANGUARD INDEX FDS | 25.76% | 520.0K | $113.3M | +0.00%(+0) | $188.74(+20.54%) | 2026-06-30 | |
| INDA | ISHARES TR | 4.15% | 369.6K | $18.3M | +0.00%(+0) | $41.08(+21.07%) | 2026-06-30 | |
| ORIC | ORIC PHARMACEUTICALS INC | 2.44% | 989.4K | $10.7M | +0.00%(+0) | $23.92(-42.02%) | 2026-06-30 | |
| FHTX | FOGHORN THERAPEUTICS INC | 1.75% | 1.57M | $7.7M | +0.00%(+0) | $17.54(-64.31%) | 2026-06-30 | |
| PMVP | PMV PHARMACEUTICALS INC | 0.8% | 2.63M | $3.5M | +0.00%(+0) | $43.77(-97.11%) | 2026-06-30 | |
| ALEC | ALECTOR INC | 0.6% | 1.31M | $2.6M | +0.00%(+0) | $11.19(-82.48%) | 2026-06-30 | |
| SRZN | SURROZEN INC | 0.52% | 87.7K | $2.3M | +0.00%(+0) | $32.96(-27.31%) | 2026-06-30 | |
| TNYA | TENAYA THERAPEUTICS INC | 0.17% | 1.02M | $751K | +0.00%(+0) | $19.03(-96.17%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +14.17% | +48.83% | -13.74% | -52.24% |
| Top 20 Holdings Unweighted | +0.23% | +0.68% | -18.69% | -64.46% |
Euclidean Capital LLC reports $439.84M in US-listed equity holdings across 11 positions in its most recent 13F filing. Its largest disclosed positions are VEU (61.8%), VTV (25.8%) and INDA (4.2%). The top 20 holdings account for 97.95% of reported assets. Its disclosed equity book has returned +48.83% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Sign up free to track Euclidean Capital LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Euclidean Capital LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1825034). View Euclidean Capital LLC’s 13F filings on SEC